Want to see IN:GRANULES full AI Analyst Report?
GRANULES Stock Chart & Stats
₹833.65
₹9.25(1.11%)
At close: 4:00 PM EDT
₹833.65
₹9.25(1.11%)
Day’s Range― - ―
52-Week Range₹433.00 - ₹910.00
Previous CloseN/A
Volume917.48K
Average Volume (3M)56.05K
Market Cap
₹204.20B
Enterprise Value₹157.75K
Total Cash (Recent Filing)₹6.26B
Total Debt (Recent Filing)₹18.07B
Price to Earnings (P/E)30.5
Beta0.81
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.21%
Share Statistics
EPS (TTM)21.14
Shares Outstanding247,796,920
10 Day Avg. Volume60,875
30 Day Avg. Volume56,048
Financial Highlights & Ratios
PEG Ratio1.39
Price to Book (P/B)2.97
Price to Sales (P/S)2.81
P/FCF Ratio125.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)32.03
Revenue Forecast (FY)₹62.31B
Bulls Say, Bears Say
Bulls Say
Vertical Integration (APIs→PFIs→FDF)Integrated manufacturing across APIs, PFIs and FDFs reduces reliance on external suppliers, lowers input-cost volatility, and improves internal supply reliability. This structural vertical integration supports durable cost advantages, steadier production and stronger contract credibility over months.
Resumed Revenue GrowthRevenue returned to growth in FY2026 (+10.9%), signalling resilient end-market demand and improved capacity utilization after flat years. Sustainable top-line momentum helps absorb fixed costs, supports longer-term planning, and underpins multi-quarter earnings stability if maintained.
Conservative LeverageDebt-to-equity near 0.39–0.43 is conservative for a manufacturing firm, preserving financial flexibility for capex or working-capital needs. Stable leverage reduces refinancing risk and supports continued investment in capacity and compliance needed for regulated markets over the medium term.
Bears Say
Margin Compression / Gross Profit DeclineGross profit declined in FY2026 even as revenue rose, indicating cost or pricing pressures that compress margins. Persistent margin erosion would weaken earnings quality and limit the firm's ability to convert sales into cash and returns, requiring structural cost fixes or better pricing to reverse.
Uneven Cash Conversion / FCF WeaknessOperating cash flow is positive but free cash flow has been volatile, with FY2026 FCF down ~19%. Inconsistent cash conversion suggests working-capital or capex absorption that can constrain debt reduction, reinvestment, or shareholder distributions across several quarters.
Falling Return On EquityROE falls from ~25% to mid-teens imply lower capital productivity and diminished returns on incremental investments. If this trend persists, shareholders may see weaker long-term return generation absent margin recovery or higher sustainable growth rates.
Granules India Limited News
GRANULES FAQ
What was Granules India Limited’s price range in the past 12 months?
Granules India Limited lowest stock price was ₹433.00 and its highest was ₹910.00 in the past 12 months.
What is Granules India Limited’s market cap?
Granules India Limited’s market cap is ₹204.20B.
When is Granules India Limited’s upcoming earnings report date?
Granules India Limited’s upcoming earnings report date is Nov 05, 2026 which is in 94 days.
How were Granules India Limited’s earnings last quarter?
Granules India Limited released its earnings results on Jul 21, 2026. The company reported ₹6.95 earnings per share for the quarter, missing the consensus estimate of ₹7.7 by -₹0.75.
Is Granules India Limited overvalued?
According to Wall Street analysts Granules India Limited’s price is currently Overvalued.
Does Granules India Limited pay dividends?
Granules India Limited pays a Annually dividend of ₹1.75 which represents an annual dividend yield of 0.21%. See more information on Granules India Limited dividends here
What is Granules India Limited’s EPS estimate?
Granules India Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Granules India Limited have?
Granules India Limited has 247,796,920 shares outstanding.
What happened to Granules India Limited’s price movement after its last earnings report?
Granules India Limited reported an EPS of ₹6.95 in its last earnings report, missing expectations of ₹7.7. Following the earnings report the stock price went down -0.057%.
Which hedge fund is a major shareholder of Granules India Limited?
Currently, no hedge funds are holding shares in IN:GRANULES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Granules India Limited
Founded in 1984 and headquartered in Hyderabad, India, Granules India Limited operates as a key player in the pharmaceutical sector. The company is engaged in the manufacturing and global distribution of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs), intermediate compounds for drug formulation, and final dosage forms (FDFs). Its API portfolio addresses various therapeutic categories, such as antiviral medications, treatments for hypertension, antihistamines, anti-infectives, pain relief agents, anticoagulants, anti-fibrinolytic drugs, and platelet inhibitors. Additionally, Granules produces a variety of FDFs, encompassing tablets, caplets, and press-fit capsules, which are supplied in bulk, blister packs, and bottles. The firm also develops specialized products for oncology. Granules India Limited maintains a broad international presence, with its products reaching markets across India, North America, Europe, Latin America, Africa, and the Middle East.
Technical Analysis
Aurobindo Pharma Ltd
―
Glenmark Life Sciences Limited
―
Jubilant Pharmova Limited
―
Laurus Labs Ltd.
―
Neuland Laboratories Ltd.
―